The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $63.86

Today's change-0.15 -0.23%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $63.86

Today's change-0.15 -0.23%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Reversal following new 50-day high

Seattle Genetics Inc closed lower Friday, dropping (U.S.)$0.15 or 0.23% to (U.S.)$63.86 after setting a new 50-day high. Over the last five days, shares have gained 1.37% and 21.02% year to date. Shares have outperformed the S&P 500 by 3.50% during the last year.

Key company metrics

  • Open(U.S.) $65.00
  • Previous close(U.S.) $64.01
  • High(U.S.) $65.15
  • Low(U.S.) $63.30
  • Bid / Ask(U.S.) $55.50 / (U.S.) $65.50
  • YTD % change+21.02%
  • Volume1,537,396
  • Average volume (10-day)1,237,378
  • Average volume (1-month)1,093,713
  • Average volume (3-month)1,211,788
  • 52-week range(U.S.) $45.31 to (U.S.) $75.36
  • Beta2.40
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.43
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue108109105106
Total other revenue--------
Total revenue108109105106
Gross profit96979495
Total cost of revenue12121211
Total operating expense167168161139
Selling / general / administrative41384135
Research & development11411810893
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-59-59-56-32
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-56-60-55-32
Income after tax-56-60-55-32
Income tax, total--------
Net income-56-60-55-32
Total adjustments to net income--------
Net income before extra. items-56-60-55-32
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-56-60-55-32
Inc. avail. to common incl. extra. items-56-60-55-32
Diluted net income-56-60-55-32
Dilution adjustment--------
Diluted weighted average shares143142142141
Diluted EPS excluding extraordinary itemsvalue per share-0.39-0.42-0.39-0.23
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.39-0.42-0.39-0.23